Search results

...maceuticals]] (acquired by [[Gilead Sciences]] in 1999). It is marketed by Gilead in Europe and licensed to [[Astellas Pharma]] (formerly Fujisawa Pharmaceut [[Category:Gilead Sciences]]

...title -->]</ref> Triangle Pharmaceuticals was acquired in 2003 by [[Gilead Sciences]], who completed development and now market the product with the brand name [[Category:Gilead Sciences]]

...42-6405-3-29 | pmid=17132170 | pmc=1687192 }}</ref>), marketed by [[Gilead Sciences]] under the trade name '''Viread''', belongs to a class of [[antiretroviral ...ine is marketed as a single-compound product called '''Emtriva''', also by Gilead.) '''[[Atripla]]''', a fixed-dose triple combination of tenofovir, emtricit

...nation]] drug for the treatment of [[HIV]] infection. It combines [[Gilead Sciences]]'s [[tenofovir]] and [[emtricitabine]] (already available in the anti-HIV In North America and Europe, Atripla is marketed jointly by [[Gilead Sciences]] and [[Bristol-Myers Squibb]], but in much of the developing world, market

Truvada was developed by [[Gilead Sciences]] and approved by the Untited States' [[Food and Drug Administration]] in 2 *[http://www.truvada.com Truvada website], run by Gilead Sciences